Common Stock (Details Narrative) - USD ($)					1 Months Ended				6 Months Ended
	May 01, 2025	Dec. 05, 2024	Aug. 08, 2024	Mar. 12, 2024	Jun. 15, 2025	May 28, 2025	Mar. 24, 2025	Mar. 20, 2025	Jun. 30, 2025	Dec. 31, 2024
Common Stock, Shares Authorized									325,000,000	325,000,000
Common stock shares issued during period, new issues	1,958,273
Proceeds from stock options and warrants exercised	$ 1,958
Exercise price per share	$ 0.001
Common Stock, Shares Par Value									$ 0.001	$ 0.001
Common Stock, Shares Issued									103,982,020	96,097,485
Common Stock, Shares Outstanding									103,982,020	96,097,485
Issued shares of restricted common stock									828,271
Stock Options [Member]
Options, cancelled in period					51,722	171,291		26,200
Securities Purchase Agreement [Member]
Agreement of several purchases offering, Description		(i) 445,648 shares to the Insider Investors at an offering price of $0.5722 per share and (ii) a further 2,857,389 shares of our common stock (the “December 2024 Warrant Investor Shares” and, together with the Insider Shares, the “December 2024 Shares”), together with 2,857,389 common stock purchase warrants to purchase up to 2,857,389 shares of our common stock (the “Form A Warrants”) and 2,857,389 common stock purchase warrants to purchase up to 1,428,693 shares of our common stock (the “Form B Warrants” and, together with the Form A Warrants, the “December 2024 Warrants”), at a combined offering price of $0.5722 per December 2024 Warrant Investor Share and accompanying December 2024 Warrants, to certain existing stockholders of the Company and new investors. The December 2024 Shares, Form A Warrants, and Form B Warrants were separately issued. Each Form A Warrant has an exercise price per share of $0.5722 and each Form B Warrant has an exercise price per share of $0.71525. Each December 2024 Warrant is exercisable on or after December 9, 2024 through and until December 9, 2029. The net proceeds received by the Company for the issuance and sale of the December 2024 Shares and the December 2024 Warrants was $1.9 million, before deducting offering expenses of $0.1 million paid by the Company					(i) 2,363,636 shares of the Company’s common stock to certain of its directors and executive officers, and certain of its existing stockholders (collectively, the “Insiders”) at an offering price of $0.55 per share (the “Insider Shares”), and (ii) 1,739,087 shares of common stock (the “March 2025 Warrant Investor Shares” and, together with the Insider Shares, the “March 2025 Shares”), together with common stock purchase warrants to purchase up to 1,739,087 shares of common stock (the “March 2025 Warrants”), at a combined offering price of $0.55 per March 2025 Warrant Investor Share and accompanying March 2025 Warrant, to certain other existing stockholders of the Company and new investors. Each March 2025 Warrant has an exercise price per share of $0.66, and is exercisable on or after March 26, 2025 through and until March 26, 2030. The Insiders did not receive any March 2025 Warrants in the offering. The net proceeds received by the Company for the issuance and sale of the March 2025 Shares and the March 2025 Warrants was $2.3 million, before deducting offering expenses of $0.1 million paid by the Company
Common stock shares sold			9,170,000
Pre-Funded Warrants			3,557,273
Exercise price			$ 0.001
Offering price			$ 0.55
Offering expenses			$ 100,000
Issuance and sale of the Securities			$ 6,400,000
Warrants issued to purchase common shares			381,818
Securities Purchase Agreement [Member] | Series B Warrants [Member]
Pre-Funded Warrants			12,727,273
Exercise price			$ 0.57
Securities Purchase Agreement [Member] | Series A Warrants [Member]
Pre-Funded Warrants			12,727,273
Exercise price			$ 0.57
Offering price			$ 0.549
License Agreement
Issued shares of restricted common stock				129,132
Price per share				$ 0.97
2022 EDA [Member]
Common stock shares sold									1,945,838
Commissions and fee									$ 2,400,000
Equity Distribution Agreement [Member]
Common stock shares sold									448,706
Commissions and fee									$ 262,484
2025 ATM Sales Agreement [Member]
Common stock shares sold									321,562
Description of sales agreement									the Company entered into a Capital On DemandTM Sales Agreement (the “2025 ATM Sales Agreement”) with JonesTrading Institutional Services, LLC (“JonesTrading”) to sell shares of the Company's common stock, with an aggregate offering price of up to $7.5 million, from time to time through an “at the market” offering pursuant to the Company's Registration Statement on Form S-3 filed November 8, 2024
Commissions and fee									$ 161,075